Medtronic PLC (MDT) Stock AnalysisMDTMedtronic PLC

Medtronic plc is an Ireland-based healthcare technology company. The Company's technologies and therapies treat approximately 70 health conditions and include cardiac devices, surgical robotics, surgical tools, patient monitoring systems, and more. Its product category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral Maxillofacial & Dental; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging and Urological. Its services and solutions include Ambulatory Surgery Center Resources, Digital Connectivity Information Technology (IT) Support, Equipment Services & Support, Financial Services, Innovation Lab and Office-Based Sinus Surgery. Its medical specialties include Cardiac Surgery, Electrophysiology, Gastroenterology, Hernia Repair, Interventional Cardiology and Spine Surgery. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Medtronic PLC is a good buy right now due to its current price of $95.41, a forward P/E ratio of 14.93, and a strong gross margin of 61.97%. The company has also raised its quarterly dividend for 49 consecutive years, indicating solid financial health and commitment to shareholders. However, a risk to consider is the recent insider selling trend, which has increased by 306.25% over the last month, suggesting some caution among insiders.

23 analysts cover MDT: 11 rate it Buy, 12 Hold and 0 Sell. The average price target is 111.76.